Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol - Wikidata - wikimedia - TriplyDB

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

http://www.wikidata.org/entity/Q28652334

about

Novel therapeutic agents in the treatment of metastatic colorectal cancer Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

P2860

Q26769932-EEAF6093-4C1B-4950-A234-92302C9ED6BA Q37143791-E2645E74-4631-4411-A020-CA15BA6DE89B Q54113620-79C30C52-7BFB-41B6-9AF1-1A9071619C9B

P2860

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

http://www.wikidata.org/entity/Q28652334

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@ast

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@en

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@nl

type

label

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@ast

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@en

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@nl

prefLabel

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@ast

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@en

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@nl

P1433

Q28652334-17599BDA-5599-4353-A807-5E1D7BB386C1

P1476

Q28652334-6F648956-E314-4DDD-A0E5-E329128A7243

P2093

Q28652334-1FD921B6-939E-4FD9-AAFB-C0D5C650B6DD

Q28652334-335C6F7C-46AB-476D-B2C0-BE57B78A725D

Q28652334-3587F1DC-8C4D-4431-BF98-D6DC27714265

Q28652334-3D02837E-C801-42A6-A833-B4CFCD45BB7A

Q28652334-4504B5DE-4EFC-48C5-B38F-20DBC42BF997

Q28652334-6A5546F2-190B-4CC5-A441-B660ED5E0347

Q28652334-86661BC0-6FAC-49FE-9F42-79675B8BCB24

Q28652334-CDD60341-58F9-4CF5-9B8F-307455645238

P2860

Q28652334-0AC02F09-5C79-414D-964E-CF0FE01FBFEF

Q28652334-13975F0A-C7C3-4B69-89AA-B386943B4385

Q28652334-14CCB699-118D-4808-9D7E-B5AF1B947C3D

Q28652334-1B53E115-E7F5-4379-821C-8369CDD4A4B2

Q28652334-26292917-FFB9-4A69-8599-A05B0E7A1B98

Q28652334-3132C26B-202C-4AFE-A40D-6A8FC54AEA45

Q28652334-3F4733C7-C52F-48B9-8DD5-777D695A08B3

Q28652334-7911F09E-CD28-4C83-868E-69266BF6C691

Q28652334-80397ED0-8BF8-4FCF-9898-66B50DEE71C8

Q28652334-888390BB-97B8-4E4D-9230-1CBB5692C8B7

P304

Q28652334-F5A685E0-1429-4683-BB09-80883E4C603C

P31

Q28652334-8BAEC7F0-480D-42E2-A3D2-80C7A06E0BAE

P3181

Q28652334-3CC71343-BBD0-4A5E-951F-C9D4D780C2D2

P356

Q28652334-A7D95CA0-6503-43D2-B20A-182C55D040F7

P407

Q28652334-12279776-436A-4C47-8613-89CB54F2F177

P433

Q28652334-60B520B3-FF12-45CC-884A-3599198D65BC

P478

Q28652334-B26AA66F-391C-4775-9E7C-6B3B891E878B

P577

Q28652334-51DE9F48-16A4-4EB1-89DC-65FBD6F7052E

P5875

Q28652334-2F2C1304-DFEB-49E2-AF28-AB98441D988D

P698

Q28652334-D23165E5-1502-4029-81A3-446574644C3B

P921

Q28652334-19B435B1-01AF-445C-AB71-3FA7B5289BDF

P932

Q28652334-4F8D3E6F-9099-428A-8029-B64BAB233251

P3181

P356

BMJOPEN-2014-007189

P1433

P1476

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol

@en

P2093

Alain Hendlisz

http://www.w3.org/2001/XMLSchema#string

Amélie Deleporte

http://www.w3.org/2001/XMLSchema#string

Camilo Garcia

http://www.w3.org/2001/XMLSchema#string

Caroline Vandeputte

http://www.w3.org/2001/XMLSchema#string

Marianne Paesmans

http://www.w3.org/2001/XMLSchema#string

Nicolas Charette

http://www.w3.org/2001/XMLSchema#string

Patrick Flamen

http://www.w3.org/2001/XMLSchema#string

Thomas Guiot

http://www.w3.org/2001/XMLSchema#string

P2860

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Estimating the world cancer burden: Globocan 2000.

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

Molecular imaging of cancer with positron emission tomography.

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study.

A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors.

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer.

P304

e007189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2360310

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJOPEN-2014-007189

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273386616

http://www.w3.org/2001/XMLSchema#string

P698

25753361

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4360786

http://www.w3.org/2001/XMLSchema#string